Bloomberg Technology
@bloombergtech·728K subscribers·13.9K videos
Alphabet's Isomorphic Labs: Turning Cancer Into a Chronic, But Livable Disease
Posted
September 14, 2025
Views
10,517
Likes
309
Comments
31
Engagement
September 14, 2025
10,517
309
31
3.23%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
21:42Now PlayingIsomorphic Labs, a subsidiary of Alphabet Inc., is trying to use artificial intelligence to understand biology and transform the way new medicines are discovered and developed. Bloomberg's Tom Mackenzie spoke exclusively with the company's Chief AI Officer Max Jaderberg and its Head of Medicinal Drug Design Rebecca Paul about the technology behind their drug design engine and how it could reshape the future of healthcare, potentially turning cancer in a chronic, but livable disease.
Watch the full episode
Chapters:
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on...
Follow Ed Ludlow on X here
Follow Caroline Hyde on X here
Listen to the daily Bloomberg Technology podcast here:
More from Bloomberg Business
Connect with us on...
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
